Tenpoint Therapeutics

London, United Kingdom · Founded 2019 · Privately Held (backing)

Operator of a biotechnology platform intended to restore vision for people with degenerative ocular diseases. Tenpoint Therapeutics is based in London, United Kingdom and was founded in 2019. Its last reported valuation was $76.6 million in Jul 2023. It has raised $312 million.

Last reported valuation
$76.6M
Oct 2026
Priced at
—
Total raised
$312.1M
Last round
—

Who backs Tenpoint Therapeutics?

15 investors
InvestorType
F-Prime CapitalVenture capital
Qiming Venture Partners USAVenture capital
Eight RoadsAsset manager
British Business BankOther
Hillhouse Investment GroupOther
Sofinnova PartnersVenture capital
EQT Life SciencesVenture capital
Wille FinanceFamily office
AdBio partners—
EQT—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Tenpoint Therapeutics investors

15 investors are on record for Tenpoint Therapeutics, including F-Prime Capital, Qiming Venture Partners USA, Eight Roads and British Business Bank. By type, the record holds 4 venture capital firms and 1 family office.

Free account
More of Tenpoint Therapeutics with a free account
  • ·The complete investor list: 15 names
  • ·Watch Tenpoint Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Tenpoint Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View